Rockley Photonics Holdings (OTCPK:RKLY.Q) - Aktienkurs, Nachrichten und Analyse

RKLY.Q Aktienübersicht

Rockley Photonics Holdings Limited develops and supplies silicon photonics in the United Kingdom and internationally.

RKLY.Q fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	2/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

Belohnungen

Prognostiziertes jährliches Umsatzwachstum 196.17%

Im Vergleich zu Wettbewerbern und der Branche gut bewertet

Risikoanalyse

Hat keine nennenswerte Marktkapitalisierung ($929K)

Negatives Eigenkapital

Stark schwankender Aktienkurs in den letzten 3 Monaten

Die Aktionäre wurden im vergangenen Jahr verwässert

+ 1 mehr Risiko

Rockley Photonics Holdings Limited Wettbewerber

Odyssey Semiconductor Technologies

OTCPK:ODII

US$1.3m

Sun Pacific Holding

OTCPK:SNPW

US$497.3k

P2 Solar

OTCPK:PTOS

US$299.0k

WiSA Technologies

NasdaqCM:WISA

US$11.1m

Preisentwicklung & Leistung

Summary of all time highs, changes and price drops for Rockley Photonics Holdings
Historical stock prices
Current Share Price	US$0.007
52 Week High	US$5.14
52 Week Low	US$0.0002
Beta	0.55
1 Month Change	-74.07%
3 Month Change	-96.54%
1 Year Change	-99.83%
3 Year Change	-99.93%
5 Year Change	n/a
Change since IPO	-99.93%

Aktuelle Nachrichten und Updates

Recent updates

Rockley Photonics promotes Richard Meier to CEO, replacing Andrew Rickman

Dec 12

Rockley Non-GAAP EPS of $0.14 beats by $0.40, revenue of $0.56M misses by $0.94M

Nov 09

Aktionärsrenditen

	RKLY.Q	US Semiconductor	US Markt
7D	-17.6%	7.5%	1.0%
1Y	-99.8%	100.8%	20.8%

Rendite im Vergleich zur Industrie: RKLY.Q unter dem Niveau der Branche US Semiconductor, die im vergangenen Jahr eine Rendite von 84.4% erzielte.

Rendite vs. Markt: RKLY.Q hinter dem Markt US zurück, der im vergangenen Jahr eine Rendite von 25.6 erzielte.

Preisvolatilität

Is RKLY.Q's price volatile compared to industry and market?
RKLY.Q volatility
RKLY.Q Average Weekly Movement	46.9%
Semiconductor Industry Average Movement	6.3%
Market Average Movement	5.7%
10% most volatile stocks in US Market	15.4%
10% least volatile stocks in US Market	2.9%

Stabiler Aktienkurs: RKLY.QDer Aktienkurs des Unternehmens war in den letzten 3 Monaten unbeständig.

Volatilität im Zeitverlauf: RKLY.QDie wöchentliche Volatilität der Aktie ist im vergangenen Jahr von 28% auf 47% gestiegen.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
2013	302	Randy Meier	www.rockleyphotonics.com

Rockley Photonics Holdings Limited's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Rockley Photonics Holdings im Vergleich zum Marktanteil des Unternehmens?
RKLY.Q grundlegende Statistiken
Marktanteil	US$929.23k
Gewinn(TTM)	-US$166.29m
Umsatz(TTM)	US$5.43m

0.2x

Kurs-Umsatz-Verhältnis

0.0x

Kurs-Gewinn-Verhältnis

Ist RKLY.Q zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
RKLY.Q Gewinn- und Verlustrechnung (TTM)
Einnahmen	US$5.43m
Kosten der Einnahmen	US$7.43m
Bruttogewinn	-US$2.00m
Sonstige Ausgaben	US$164.30m
Umsatz	-US$166.29m

Zuletzt gemeldete Gewinne

Sep 30, 2022

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	-1.25
Bruttomarge	-36.75%
Nettogewinnspanne	-3,061.94%
Schulden/Eigenkapital-Verhältnis	-222.7%

Wie hat sich RKLY.Q auf lange Sicht entwickelt?

Historische Performance und Vergleiche

RKLY.Q Aktienübersicht

Belohnungen

Risikoanalyse

Rockley Photonics Holdings Limited Wettbewerber

OTCPK:ODII

US$1.3m

OTCPK:SNPW

US$497.3k

OTCPK:PTOS

US$299.0k

NasdaqCM:WISA

US$11.1m

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Bragar Eagel & Squire, P.C. Files Class Action Lawsuit Against Rockley Photonics Holdings Limited

Rockley Photonics Begins Sampling Bioptx™ Biosensing Band and Platform

Robbins Geller Rudman & Dowd LLP Announces the Rockley Class Action Lawsuit Charges Sc Health Holdings Limited, Sc Health Group Limited, Sin Capital Group Pte. Ltd. and Certain of Sc Health, Sin Capital Group Pte. Ltd

Rockley Photonics Advances Non-Invasive Blood Glucose Monitoring

Rockley Photonics Advances Development of Its Wearable, Laser-Based Blood Pressure Monitor with Successful Completion of Human Studies

Rockley Photonics Holdings Limited Launches Developer Platform for Biomarker Data Collection in Free-Living Conditions

Recent updates

Bragar Eagel & Squire, P.C. Files Class Action Lawsuit Against Rockley Photonics Holdings Limited

Rockley Photonics Begins Sampling Bioptx™ Biosensing Band and Platform

Robbins Geller Rudman & Dowd LLP Announces the Rockley Class Action Lawsuit Charges Sc Health Holdings Limited, Sc Health Group Limited, Sin Capital Group Pte. Ltd. and Certain of Sc Health, Sin Capital Group Pte. Ltd

Rockley Photonics Advances Non-Invasive Blood Glucose Monitoring

Rockley Photonics Advances Development of Its Wearable, Laser-Based Blood Pressure Monitor with Successful Completion of Human Studies

Rockley Photonics Holdings Limited Launches Developer Platform for Biomarker Data Collection in Free-Living Conditions

Rockley Photonics Holdings Limited(NYSE:RKLY) dropped from S&P TMI Index

Rockley Photonics Holdings Limited Filed for Bankruptcy

Rockley Photonics Announces Receipt of Notice from NYSE of Non-Compliance with Continued Listing Standards

Rockley Photonics Holdings Limited Announces Appointment of Richard Edward Kuntz as Director, with Effect from August 8, 2022

Rockley Photonics Holdings Limited Announces Management Changes

Rockley Photonics promotes Richard Meier to CEO, replacing Andrew Rickman

Rockley Photonics Demonstrates Compact 4-Kelvin Silicon Photonics Modulator Enabling Interconnect Technologies for Ultra-Sensitive Image Detection and Sensing Devices

Consensus forecasts updated

High number of new and inexperienced directors

Price target increased to US$8.00

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Rockley Non-GAAP EPS of $0.14 beats by $0.40, revenue of $0.56M misses by $0.94M

Rockley Photonics Holdings Limited to Report Q3, 2022 Results on Nov 09, 2022

Rockley Photonics Holdings Limited Appoints Richard A. "Randy" Meier as Chief Financial Officer

Rockley Photonics Holdings Limited Completes Human Study Demonstrating Promising Intra-Subject Tracking Against Standard Blood Pressure Cuff, Utilizing Its Non-Invasive, Cuffless, and Laser-Based Device

Rockley Photonics hires Richard Meier as CFO

Rockley Photonics Holdings Limited announced that it has received $12.4 million in funding

Rockley Photonics raises additional financing

Rockley Photonics Holdings Limited Unveils Next-Generation, Higher-Density Laser Spectrophotometer Chip for Wearable Health Monitoring

Consensus EPS estimates fall by 16%

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Rockley Photonics Holdings Limited Establishes Scientific Advisory Board of Prominent Scientists and Medical Experts

Rockley Photonics Names Richard Kuntz, M.D., M.Sc., to Its Board of Directors, Effective August 8, 2022

Rockley Photonics signs supply agreement for non-invasive biosensing wristband

Rockley Photonics enter partnership with leading contract research organization

Rockley Photonics Holdings Limited to Report Q2, 2022 Results on Aug 11, 2022

Rockley Photonics Holdings Limited Announces Biosensing Technology Enters Evaluation Phase by Leading Consumer Wearables Customer

Rockley Photonics Announces Senior Leadership Changes

Rockley Photonics Holdings Limited Provides Revenue Guidance for the Fiscal Year 2022

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Rockley Photonics Holdings Limited Announces Shipment of Vitalspex Pro Biosensing Technology for Alcohol, Lactate, and Glucose Measurement

No longer forecast to breakeven

High number of new directors

Rockley Photonics Holdings Limited Announces Termination of Chief Operating Officer, Amit Nagra

Rockley Photonics Holdings Limited to Report Q1, 2022 Results on Apr 27, 2022

Chief Operating Officer exercised options to buy US$614k worth of stock.

Independent Director recently bought US$197k worth of stock

No longer forecast to breakeven

Rockley Photonics Holdings Limited Revises Revenue Guidance for the Fiscal Year 2022

Forecast to breakeven in 2024

Rockley Photonics Appoints Nicolaus Henke as Independent Director and Member of Nominating & Corporate Governance Committee

Rockley Photonics Promotes Industry Leaders to Key Senior Roles

Rockley Photonics Announces Bioptx™ Biomarker Sensing Platform for Professional Healthcare, Including First-of-its-Kind Non-Invasive, Continuous Biosensing Wristband

Chief Operating Officer exercised options to buy US$1.6m worth of stock.

Rockley Photonics Holdings Limited, Annual General Meeting, May 16, 2022

Rockley Photonics Reaches Key Milestone in the Development of Cuffless, Non-Invasive Blood Pressure Measurement on the Wrist, Potentially Enabling A New Measurement Technique for Cardiovascular Health

Forecast to breakeven in 2024

High number of new and inexperienced directors

Rockley Photonics Holdings Limited Announces Results of Preliminary Human Studies Involving Measurement of Core Body Temperature

Lead Independent Director recently bought US$165k worth of stock

Third quarter 2021 earnings released: US$0.54 loss per share

Rockley Photonics: Long Term Potential Of Wearables Chip Maker Is Truly Vast

Aktionärsrenditen

Erträge & Einnahmen